Load-induced Changes in Glenohumeral Translation in Patients With Rotator Cuff Tear (LiTrans)

April 10, 2024 updated by: University Hospital, Basel, Switzerland

LiTrans - Influence of Additional Weight Carrying on Load-induced Changes in Glenohumeral Translation in Patients With Rotator Cuff Tear - a Translational Approach

The study is to investigate the dose-response relationship between load-induced muscle activation (liMA) and load-induced glenohumeral translation (liTr) in patients with rotator cuff tears and asymptomatic control subjects.

Furthermore the study is to investigate the in vivo dose-response relationship between additional weight and glenohumeral translation, to understand the biological variation in liTr, the influence of disease pathology on the liTr, the potential compensation by muscle activation and muscle size, and the influence of liTr on patient outcomes.

Study Overview

Detailed Description

This project is to test the overall hypothesis that rotator cuff tear affects glenohumeral translation and that this functional instability depends on additional load applied, on anatomical and morphological variations, and on type and severity of the injury. The study is to investigate the dose-response relationship between load-induced muscle activation (liMA) and load-induced glenohumeral translation (liTr) in patients with rotator cuff tears and asymptomatic control subjects.

Furthermore the study is to investigate the in vivo dose-response relationship between additional weight and glenohumeral translation, to understand the biological variation in liTr, the influence of disease pathology on the liTr, the potential compensation by muscle activation and muscle size, and the influence of liTr on patient outcomes.

This study entails cross-sectional experimental multimodal (clinical, biomechanical, radiological) data collection with multiple conditions and a control group.

Study Type

Interventional

Enrollment (Actual)

75

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Basel, Switzerland, 4031
        • Department of Orthopaedics and Traumatology, University Hospital Basel

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 85 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

We will examine a cohort of 75 subjects:

  • Group 1: 25 patients with unilateral symptomatic rotator cuff tear between 45 and 85 years
  • Group 2: 25 asymptomatic control subjects (age and sex distribution matching the patient group) Group 3: 25 sex matched young asymptomatic control subjects between 20 and 30 years

Inclusion criteria patients:

  • Diagnosed unilateral rotator cuff tear
  • Partial or complete supraspinatus muscle tear
  • With or without injury to other rotator cuff muscles

Exclusion criteria patients:

  • Prior operative treatment of the ipsilateral shoulder or elbow
  • Clinical history or symptoms of the contralateral glenohumeral joint
  • Range of motion <30° in abduction and flexion

Inclusion criteria asymptomatic control subjects:

- No previous known elbow and shoulder injury or symptoms

Exclusion criteria asymptomatic control subjects:

  • Clinical history of the glenohumeral joint
  • Prior conservative or operative treatment of the shoulder or elbow
  • Range of motion <90° in abduction and flexion

General exclusion criteria:

  • Inability to provide informed consent
  • Body mass index (BMI) > 35 kg/m2 (Excessive skin movement)
  • Neuromuscular disorders affecting upper limb movement
  • Additional pathologies that influence the mobility of the shoulder joints
  • Contraindications for MRI (e.g. neurostimulator and claustrophobia)
  • Prior neuromuscular impairment (e.g. stroke)
  • Diagnosed active rheumatic disorder
  • Other major medical problems
  • Pregnancy
  • Patients currently enrolled in another experimental (interventional) protocol

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Diagnostic
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Group 1: patient group (unilateral rotator cuff tear)
Group 1: 25 patients with unilateral symptomatic rotator cuff tear
30° arm abduction in the scapular plane will be performed with and without a handheld weight of 1, 2, 3, and 4 kg. All movements will be done bilaterally. Electromyographic (EMG) data of arm and trunk muscles will be recorded using surface electrodes. Participants will be asked to perform full arm abduction with different rotations (internal, neutral and external rotation), flexion and internal-/external rotations movements (without additional handheld weight).
isometric shoulder strength for abduction and internal/external rotation will be assessed with a isometric shoulder strength for abduction and internal/external rotation will be assessed with a dynamometer
fluoroscopic images (Multitom Rax, Siemens Healthineers, Erlangen, Germany) of each shoulder will be taken during the 30° arm abduction test with and without a handheld weight (0, 2, and 4kg)
MRI of both shoulders will be taken
data collection by health questionnaires
Other: Group 2: control group (asymptomatic volunteers)
Group 2: (asymptomatic volunteers) 25 asymptomatic control subjects (age and sex distribution matching the patient group)
30° arm abduction in the scapular plane will be performed with and without a handheld weight of 1, 2, 3, and 4 kg. All movements will be done bilaterally. Electromyographic (EMG) data of arm and trunk muscles will be recorded using surface electrodes. Participants will be asked to perform full arm abduction with different rotations (internal, neutral and external rotation), flexion and internal-/external rotations movements (without additional handheld weight).
isometric shoulder strength for abduction and internal/external rotation will be assessed with a isometric shoulder strength for abduction and internal/external rotation will be assessed with a dynamometer
fluoroscopic images (Multitom Rax, Siemens Healthineers, Erlangen, Germany) of each shoulder will be taken during the 30° arm abduction test with and without a handheld weight (0, 2, and 4kg)
MRI of both shoulders will be taken
data collection by health questionnaires
Other: Group 2: young control group (young asymptomatic volunteers)
Group 3: (young asymptomatic volunteers) 25 asymptomatic control subjects, 20 to 30 years (sex distribution matching the patient group)
30° arm abduction in the scapular plane will be performed with and without a handheld weight of 1, 2, 3, and 4 kg. All movements will be done bilaterally. Electromyographic (EMG) data of arm and trunk muscles will be recorded using surface electrodes. Participants will be asked to perform full arm abduction with different rotations (internal, neutral and external rotation), flexion and internal-/external rotations movements (without additional handheld weight).
isometric shoulder strength for abduction and internal/external rotation will be assessed with a isometric shoulder strength for abduction and internal/external rotation will be assessed with a dynamometer
fluoroscopic images (Multitom Rax, Siemens Healthineers, Erlangen, Germany) of each shoulder will be taken during the 30° arm abduction test with and without a handheld weight (0, 2, and 4kg)
MRI of both shoulders will be taken
data collection by health questionnaires

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Disabilities of arm, shoulder and hand (Quick DASH) questionnaire
Time Frame: at baseline (approximate duration for all questionnaires: 20 minutes)
30-item questionnaire that looks at the ability of a patient to perform certain upper extremity activities. This questionnaire is a self-report questionnaire that patients can rate difficulty and interference with daily life on a 5 point Likert scale (1 being no difficulty, 5 being unable).
at baseline (approximate duration for all questionnaires: 20 minutes)
Constant Score
Time Frame: at baseline (approximate duration for all questionnaires: 20 minutes)
The Constant-Murley score (CMS) is a 100-points scale composed of a number of individual parameters. These parameters define the level of pain and the ability to carry out the normal daily activities of the patient. The test is divided into four subscales: pain (15 points), activities of daily living (20 points), strength (25 points) and range of motion: forward elevation, external rotation, abduction and internal rotation of the shoulder (40 points). The higher the score, the higher the quality of the function.
at baseline (approximate duration for all questionnaires: 20 minutes)
American Shoulder and Elbow Surgeons (ASES) Shoulder Score
Time Frame: at baseline (approximate duration for all questionnaires: 20 minutes)
The American Shoulder and Elbow Surgeons Shoulder Score (ASES) is a mixed outcome reporting measure, applicable for use in all patients with shoulder pathology regardless of their specific diagnosis. The ASES questionnaire is composed of both a physician-rated component and a patient-reported component. The patient questions focus on joint pain, instability, and activities of daily living. The pain and functional portions are summed to obtain the final ASES score with higher scores indicating better outcomes.
at baseline (approximate duration for all questionnaires: 20 minutes)
Subjective Shoulder Value (SSV)
Time Frame: at baseline (approximate duration for all questionnaires: 20 minutes)
The SSV is defined as a patient's subjective shoulder assessment expressed as a percentage of an entirely normal shoulder, which would score 100%.
at baseline (approximate duration for all questionnaires: 20 minutes)
numerical pain rating scale (NRS) score
Time Frame: at baseline (approximate duration for all questionnaires: 20 minutes)
The Numeric Pain Rating Scale (NPRS) is a unidimensional measure of pain intensity in adults (from 0-10: "0" = no pain. "10" = the most intense pain imaginable)
at baseline (approximate duration for all questionnaires: 20 minutes)
Loaded shoulder abduction test with single plane fluoroscopic images
Time Frame: at baseline (approximate duration for motion analysis: 50 minutes).
fluoroscopic images (Multitom Rax, Siemens Healthineers, Erlangen, Germany) of each shoulder will be taken during the 30° arm abduction test with and without a handheld weight (0, 2, and 4kg)
at baseline (approximate duration for motion analysis: 50 minutes).
Load-induced muscle activity from electromyography (EMG)
Time Frame: at baseline (approximate duration for motion analysis: 50 minutes)
During arm movements in the loaded shoulder test and muscle strength tests, muscle activation of the infraspinatus, biceps brachii, anterior, middle and posterior part of the deltoid, clavicular part of the pectoralis major, latissimus dorsi and the upper part of the trapezius will be measured bilaterally using a 16-channel EMG system
at baseline (approximate duration for motion analysis: 50 minutes)
Glenohumeral translation from single plane fluoroscopy
Time Frame: at baseline (approximate duration for motion analysis: 50 minutes)
the vertical distance of the glenohumeral joint centre (GHJC) and the radiopaque acromion marker will be measured. Fluoroscopy (FL) based liTr will be calculated for each participant as the slope of the regression of the negative GHJC to acromion distance measurements on the load magnitude.
at baseline (approximate duration for motion analysis: 50 minutes)
Glenohumeral translation from instrumented motion analysis
Time Frame: at baseline (approximate duration for motion analysis: 50 minutes)
The vertical distance of the GHJC to the acromion marker will be calculated for a neutral trial and with the arm in 30° shoulder abduction for each loading condition. Motion analysis (MA) based liTr will be calculated for each participant as the slope of the regression of the negative GHJC to acromion distance measurements on the load magnitude
at baseline (approximate duration for motion analysis: 50 minutes)
Critical shoulder angle (CSA)
Time Frame: at baseline (approximate duration for motion analysis: 50 minutes)
Subject's CSA will be measured on an anterior-posterior double-obliquity fluoroscopy image of the shoulder as the angle subtended by a line parallel to the glenoid and a line through the inferior-lateral edge of the glenoid and the inferior-lateral edge of the acromion. The CSA is reproducible and significantly greater in patients with rotator cuff tears than the general population. High angles (>35°-38°) have been associated with rotator cuff tears and greater joint instability.
at baseline (approximate duration for motion analysis: 50 minutes)
Glenoid inclination (GI)
Time Frame: at baseline (approximate duration for motion analysis: 50 minutes)
GI will be measured on the fluoroscopy image as the angle between a line from the upper to the lower glenoid rim (glenoid plane) and a second line set on the floor of the supraspinous fossa. Abnormal GI might be associated with rotator cuff tears and superior humeral head migration.
at baseline (approximate duration for motion analysis: 50 minutes)
Greater tuberosity angle (GTA)
Time Frame: at baseline (approximate duration for motion analysis: 50 minutes)
GTA will be measured as the angle between a line parallel to the humerus diaphysis through the GHJC and a line from the upper border of the humeral head to the most superolateral edge of the greater tuberosity. A GTA of more than 70° has been observed to predict rotator cuff tear.
at baseline (approximate duration for motion analysis: 50 minutes)
Muscle cross sectional area (MCSA)
Time Frame: at baseline (approximate duration is approximately 1 hour and 15 minutes)
The MCSA of all rotator cuff muscles will be measured at two different positions on parasagittal reformatted images. MCSA of the deltoid will also be measured on the axial plane at the middle of the glenoid.
at baseline (approximate duration is approximately 1 hour and 15 minutes)
Tear size retrieved from MR images
Time Frame: at baseline (approximate duration is approximately 1 hour and 15 minutes)
Tear size will be classified into partial (1) or complete supraspinatus muscle tear (2).
at baseline (approximate duration is approximately 1 hour and 15 minutes)
Tear type retrieved from MR images
Time Frame: at baseline (approximate duration is approximately 1 hour and 15 minutes)
Tear type will be classified into supraspinatus tear without injury to other rotator cuff muscles (type A) and with injury to other rotator cuff muscles (type B). Both will be used as indicators for injury severity
at baseline (approximate duration is approximately 1 hour and 15 minutes)
Isometric shoulder muscle strength for abduction and internal/external rotation
Time Frame: at baseline (approximate duration: 40 minutes).
Shoulder muscle strength will be tested under isometric conditions using a dynamometer. The maximum of 3 trials will be calculated and recorded as the participant's maximum isometric strength.
at baseline (approximate duration: 40 minutes).
Loaded shoulder abduction test with motion analysis
Time Frame: at baseline (approximate duration for motion analysis: 50 minutes)
The subject will lift their arm to 30° shoulder abduction in the scapular plane, data will be captured holding 0, 1, 2, 3, and 4 kg, respectively, in their hand. Reflective surface markers will be placed bilaterally on the participants' trunk and arms. Position of these markers will be recorded using infrared cameras that only record the reflections of the markers. Additionally, inertial sensors will be positioned on the subjects' thorax, scapulae, humeri and forearms.
at baseline (approximate duration for motion analysis: 50 minutes)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Annegret Mündermann, Prof. Dr., Department of Orthopaedics and Traumatology, University Hospital Basel

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 4, 2021

Primary Completion (Actual)

December 31, 2022

Study Completion (Actual)

December 31, 2023

Study Registration Dates

First Submitted

March 24, 2021

First Submitted That Met QC Criteria

March 24, 2021

First Posted (Actual)

March 29, 2021

Study Record Updates

Last Update Posted (Actual)

April 12, 2024

Last Update Submitted That Met QC Criteria

April 10, 2024

Last Verified

April 1, 2024

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Rotator Cuff Tear

Clinical Trials on 3D motion analysis

Subscribe